61 results
Abrilada (adalimumab-afzb)
(adalimumab-afzb)Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, either alone or with other treatments.
Amjevita (adalimumab-atto)
(adalimumab-atto)Amgen Inc
Usage: AMJEVITA is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, aiming to reduce symptoms and improve patient function. It can be used alone or with other medications.
Avsola (infliximab-axxq)
(infliximab-axxq)Amgen Inc
Usage: AVSOLA is indicated for managing moderately to severely active Crohn's disease and ulcerative colitis in adults and pediatric patients, as well as for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults, particularly when prior therapies are inadequate.
Bimzelx (bimekizumab)
(bimekizumab)UCB, Inc.
Usage: BIMZELX is indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, active non-radiographic axial spondyloarthritis with inflammation, active ankylosing spondylitis, and moderate to severe hidradenitis suppurativa in adults.
Bryhali (halobetasol propionate)
(halobetasol propionate)Bausch Health US, LLC
Usage: BRYHALI® (halobetasol propionate) lotion, 0.01% is used for the topical treatment of plaque psoriasis in adults.
Cimzia (certolizumab pegol)
(certolizumab pegol)UCB, Inc.
Usage: CIMZIA is indicated for reducing signs and symptoms in Crohn's disease, treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, active psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and moderate-to-severe plaque psoriasis in adults and patients aged 2 and older.
Clobetasol propionate (clobetasol propionate)
(Clobetasol Propionate)Teligent Pharma, Inc.
Usage: Clobetasol Propionate Lotion 0.05% is indicated for relieving inflammatory and pruritic symptoms of corticosteroid-responsive dermatoses in adults (18+ years). Treatment is limited to 2 weeks, with possible extension for localized psoriasis. It should not be used on the face, axillae, groin, or in certain skin conditions.
Clobetasol propionate (clobetasol propionate)
(CLOBETASOL PROPIONATE)Alembic Pharmaceuticals Limited
Usage: Clobetasol propionate shampoo, 0.05%, is indicated for treating moderate to severe scalp psoriasis in adults (18+ years). Treatment is limited to 4 weeks, with a maximum dosage of 50 g per week. It should not be used on the face, groin, or axillae, and is not recommended for those under 18.
Cosentyx (secukinumab)
(secukinumab)Novartis Pharmaceuticals Corporation
Usage: COSENTYX® is indicated for moderate to severe plaque psoriasis in patients 6 years and older, active psoriatic arthritis in those 2 years and older, ankylosing spondylitis in adults, non-radiographic axial spondyloarthritis in adults, active enthesitis-related arthritis in patients 4 years and older, and moderate to severe hidradenitis suppurativa in adults.
Cyltezo (adalimumab-adbm)
(adalimumab-adbm)Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: CYLTEZO is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. It can be used alone or with non-biologic DMARDs, depending on the condition.
- ...